KARLIJN BURRIDGE: Open Payments
NPI 1750611646 · WESTMONT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$74,846 in 115 payments from 6 companies in 2025. Trend: 2023 $10,879 · 2024 $45,798 · 2025 $74,846
Consulting: $46,458Speaker / faculty: $19,500Travel & lodging: $6,234Food & beverage: $2,655
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 43 | $38,541 |
| Lilly USA, LLC | 47 | $21,090 |
| Novo Nordisk Inc | 10 | $10,299 |
| VIVUS LLC | 6 | $4,142 |
| Currax Pharmaceuticals LLC | 7 | $676 |
| Amgen Inc. | 2 | $98 |
Products named: ZEPBOUND, QSYMIA, CONTRAVE, Wegovy.
Industry payments across IL — which companies pay providers there.
